IRIS
CUCCIA, MARIACLARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.332
EU - Europa 5.189
AS - Asia 5.141
SA - Sud America 613
AF - Africa 126
Continente sconosciuto - Info sul continente non disponibili 59
OC - Oceania 13
Totale 18.473
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.182
CN - Cina 2.678
SG - Singapore 1.119
IE - Irlanda 973
IT - Italia 877
UA - Ucraina 709
DE - Germania 536
FI - Finlandia 511
RU - Federazione Russa 478
HK - Hong Kong 453
BR - Brasile 439
VN - Vietnam 433
FR - Francia 334
GB - Regno Unito 276
SE - Svezia 276
IN - India 112
CA - Canada 76
ZA - Sudafrica 73
AR - Argentina 65
BD - Bangladesh 62
MX - Messico 49
JP - Giappone 46
NL - Olanda 42
BE - Belgio 40
IQ - Iraq 36
EC - Ecuador 29
PL - Polonia 28
PK - Pakistan 24
ES - Italia 23
TR - Turchia 23
CO - Colombia 22
VE - Venezuela 18
CL - Cile 16
CZ - Repubblica Ceca 15
MA - Marocco 15
UZ - Uzbekistan 14
SA - Arabia Saudita 13
IR - Iran 12
MY - Malesia 12
PH - Filippine 12
AT - Austria 11
ID - Indonesia 11
AE - Emirati Arabi Uniti 9
AU - Australia 9
JO - Giordania 8
KZ - Kazakistan 8
PE - Perù 8
PY - Paraguay 8
AZ - Azerbaigian 7
BO - Bolivia 7
KR - Corea 7
CH - Svizzera 6
EG - Egitto 6
KE - Kenya 6
LV - Lettonia 6
TN - Tunisia 6
BG - Bulgaria 5
DO - Repubblica Dominicana 5
LB - Libano 5
LT - Lituania 5
OM - Oman 5
PA - Panama 5
AL - Albania 4
AM - Armenia 4
BH - Bahrain 4
GR - Grecia 4
IL - Israele 4
MU - Mauritius 4
NZ - Nuova Zelanda 4
SK - Slovacchia (Repubblica Slovacca) 4
AO - Angola 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
DZ - Algeria 3
HN - Honduras 3
HU - Ungheria 3
NP - Nepal 3
RO - Romania 3
BA - Bosnia-Erzegovina 2
CY - Cipro 2
EU - Europa 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
JM - Giamaica 2
KG - Kirghizistan 2
LK - Sri Lanka 2
LU - Lussemburgo 2
MK - Macedonia 2
MN - Mongolia 2
NI - Nicaragua 2
NO - Norvegia 2
PT - Portogallo 2
RS - Serbia 2
AF - Afghanistan, Repubblica islamica di 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
Totale 18.398
Salva come PNG Salva come JPEG
Città #
Chandler 973
Dublin 972
Jacksonville 819
San Jose 699
Singapore 596
Nanjing 584
Ashburn 536
Beijing 456
Hong Kong 441
Dallas 331
Boardman 328
Council Bluffs 256
Nanchang 245
Los Angeles 217
Ann Arbor 192
Princeton 176
Shenyang 176
Lawrence 171
Hebei 166
Wilmington 162
Changsha 152
Lauterbourg 150
New York 144
Medford 143
Milan 143
Helsinki 140
Buffalo 131
Jiaxing 123
Ho Chi Minh City 119
Munich 116
Hanoi 115
Tianjin 107
Hangzhou 100
Moscow 95
Rome 88
Shanghai 88
Woodbridge 69
Johannesburg 60
Orem 44
São Paulo 44
Tokyo 44
Verona 44
Piscataway 41
Santa Clara 41
Seattle 40
Toronto 39
Brussels 37
Turku 37
Pavia 36
Des Moines 33
Falkenstein 28
Chennai 27
Houston 27
Da Nang 25
Norwalk 25
Stockholm 25
Kunming 24
Redondo Beach 24
Warsaw 23
Brooklyn 22
Phoenix 21
Atlanta 20
Denver 20
Montreal 20
San Francisco 20
Chicago 19
London 19
Amsterdam 18
Auburn Hills 18
Fairfield 18
Frankfurt am Main 17
Dearborn 15
Manchester 15
Paris 14
Pune 14
Tashkent 14
Biên Hòa 13
Haiphong 13
Rio de Janeiro 13
Belo Horizonte 12
Hải Dương 12
Poplar 12
Quito 12
Jinan 11
Mumbai 11
Palermo 11
Washington 11
Zhengzhou 11
Baghdad 10
Boston 10
Caracas 10
Changchun 10
Dhaka 10
Bologna 9
Charlotte 9
Guangzhou 9
Nuremberg 9
Porto Alegre 9
The Dalles 9
Vienna 9
Totale 11.846
Salva come PNG Salva come JPEG
Nome #
Distorsione della segregazione mendeliana di particolari aplotipi HLA materni. Studio di 1580 gravidanze fisiologiche 526
Micro-ricombinazione, conversione genica e selezione positiva: un meccanismo di -molecular drive- per un'evoluzione non-darwiniana. 185
Ruolo dell'infiammazione e della risposta immune nell'aterosclerosi: studio del polimorfismo Asp299Gly del gene TLR4 (Toll Like Receptor 4) in pazienti CAD. 182
Studio di genere: possibile ruolo del polimorfismo Val66Met del BDNF nella malattia coronarica e nella depressione. 181
Age of Onset of Myocardial Infarction: Is Promoter Polymorphism of the RAGE Gene Implicated? 179
Antigen-specific T cell response in infants after recombinant hepatitis B virus vaccination at birth: evaluation of T helper lymphocyte diversity 175
"The sarcoidosis map": a joint survey of clinical and immunogenetic findings in two European countries. 157
Analisi molecolare e immunocitochimica dell'espressione del gene RAGE in pazienti CAD (Coronary Artery Disease). 155
Analysis of CR1 and CR2 polymorphisms in Italian patients with angiographically documented coronary artery disease (CAD). 151
CAD (Coronary Artery Disease) diabetes and HLA class III RAGE (Receptor for Advanced Glycation End products) gene polymorphisms. 150
Ruolo dei polimorfismi del gene TNF e dei suoi recettori (TNFR1 e TNFR2) nello sviluppo di aterosclerosi coronarica 150
Analisi immunoistochimica e molecolare (RT-PCR) di tumori umani: espressione del gene HLA-G 149
Associazione tra il polimorfismo RAGE (Receptor for Advanced Glycation Endproducts) - 374 T/A e la presenza di diabete in soggetti CAD. 148
A novel member of the Ras proto oncogene family: domain architecture, tissue specific expression and evolutionary conservation 148
Evoluzione intelligente o neo-darwiniana.? 144
-374T/A and -429 T/C polymorphisms of the RAGE gene in Myocardial Infarction. 143
Anti-darwinian intelligent evolution driven by the MHC system. 142
Activation of various laukocytes subsets after IL-2 treatment in vivo 141
Identificazione di sequenze conservate nel 30 UTR di geni coinvolti nella risposta a segnali di attivazione. 140
La genotipizzazione HLA della banca del sangue cordonale: suo potenziale utilizzo in neonatologia. 140
Evaluation of gene expression in human lymphocytes activated in the presence of melatonin 140
374T/A polymorphism of the RAGE gene promoter in relation to severity of coronary atherosclerosis 140
Infarto miocardico ed età di insorgenza: è implicato il polimorfismo -374T/A del gene RAGE nello studio di genere? 140
Studio del polimorfismo 14 bp inserzione/delezione nel gene HLA-G e insorgenza della CAD (Coronary Artery Disease) 139
Association between two polymorphisms in the HLA-G gene and angiographic coronaryartery disease 138
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men 137
Cellular and molecular actions of melatonon on lymphoid cells 136
Factors leading to the appearance, after BMT, of cytotoxic antibodies against T, B and activated T Lymphocytes: critical appraisal 133
Diversa estrinsecazione dell¿infiammazione nella Sindrome da Fatica Cronica (CFS), Sarcoidosi e Sclerosi Laterale Amiotrofica (SLA) 132
A peculiar sequence motif in the alpha-1-domain of the HLA-C molecule in Psoriasis. 132
Effetto della melatonina sulla regolazione dell'espressione genica in cellule linfoidi. 131
Association between platelet endothelial cellular adhesion molecole 1 ( PECAM-1/CD31) polymorphisms and atherosclerosis: results of a study performed in patients from north Italy 131
Infectious and autoimmune disease:an overview of gender differences 131
-374 T/A, -429 C/T and G82S polymorphisms of the receptor for advanced glycation endproducts (RAGE) gene (HLA class III) and risk of coronary artery disease (CAD) in Caucasian Italian subjects. 130
A first study of cytokine genomic polymorphisms in CFS: Positive association of TNF-857 and IFNgamma 874 rare alleles. 127
Association between platelet endothelial cellular adhesion molecule-1 polymorphisms and atherosclerosis: results of a study on patients from northern Italy 127
Aterosclerosi e CAD (Coronary artery disease): analisi dei polimorfismi del recettore CR1 126
Heat shock protein 70-hom gene polymorphism and protein expression in multiple sclerosis 126
La Sindrome da Fatica Cronica (CFS): studio Immunogenetico di una patologia misconosciuta 123
Ruolo prognostico del polimorfismo -374 T/A del gene RAGE (recettore per i prodotti finali di glicazione avanzata) nei pazienti con sospetta coronaropatia 122
MHC variation, Mate Choice and Natural Selection: The Scient of Evolution 121
A first study of cytokine genomic polymorphisms in CFS: Positive association of TNF-857 and IFNgamma 874 rare alleles. 121
Expression of receptor for advanced glycation end products in sarcoid granulomas. 121
Gene RAGE e cardiopatia ischemica: ruolo del polimorfismo –374 T/A nell’estensione della coronaropatia 121
The Possible Involvement of HLA Class III Haplotype (RAGE, HSP70 and TNF Genes) in Alzheimer's Disease 121
Cellular and molecular actions of melatonin on lymphoid cells 119
Family study of non-responsiveness to hepatitis B vaccine confirms the importance of HLA class III C$A locus. 118
HLA markers in sarcoidosis. 118
A regulatory SNP in the Promoter Region of the RAGE Gene 118
Gli aplotipi NIMA nella Banca del sangue cordonale di Pavia 118
Associazione tra il polimorfismo -374 T/A del gene RAGE (HLA classe III) e lo sviluppo di ristenosi dopo angioplastica coronarica. 117
Caratteristiche di 80 pazienti affetti da Chronic Fatigue Sindrome. 117
TRA-1 gene expression in IL-2 induced antitumoral killer cells. 115
Complement receptor 1 gene polymorphisms are associated with idiopathic pulmonary fibrosis. 115
POLIMORFISMO DEL GENE RAGE E MANIFESTAZIONI CLINICHE DELLA CARDIOPATIA ISCHEMICA 115
Brain-derived neurotrophic factor gene variants and alzheimer disease: An association study in an alzheimer disease italian population 115
Chronic Fatigue Sindrome and female gender: a genetic predisposition to autoimmunity? 114
Convergent evolution of human and bovine alleles of the DRB expressed gene. 113
Polimorfismi del gene RAGE (Receptor for Advanced Glycation Endproducts) e CAD (Coronary Artery Disease): studio dell'implicazione nell'eterogeneità di malattia 113
CD14 polymorphisms and ACS (Acute Coronary Syndromes) 112
Age of onset of myocardial infarction: is promoter polymorphism of the RAGE gene implicated? 112
Early life complement markers, IgE hyperproduction in newborn and influence of parental atopy on allergic children. 112
Hierarchy of baby-linked immunogenetic risk factors in the vertical transmission of hepatitis C virus. 111
Cellular and molecular actions of melatonin on lymphoid cells. 110
Studio genetico della provincia di Piacenza attraverso l'analisi di polimorfismi della regione HLA. 109
Extracorporeal photochemotherapy: study of HSP70-1 gene expression in human lymphocytes in vitro. 109
Role of TNF and its receptors (TNFR1, TNFR2) in Coronary Artery Disease (CAD). 108
Chronic Fatigue Sindrome: prospettive per la ricerca. 108
In vitro T-cell immune reactivity against promiscuous frames of hepatitis C virus core protein predicted by computational analysis 108
Autoantibodies, polymorphisms in the serotonin pathway, and human leukocyte antigen class II alleles in chronic fatigue syndrome: are they associated with age at onset and specific symptoms? 108
CR1 genotype and haplotype involvement in coronary artery disease: the pivotal role of hypertension and dyslipidemia 108
Extension of coronary artery lesions and RAGE (HLA class III) promoter polymorphism 107
Relationship between the -374 T/A RAGE gene polymorphism and angiographic coronary artery disease 107
Relationship between the -374 T/A Rage polymorphism and severity of coronary atherosclerosis 107
L'equilibrio tra conservazione e innovazione a livello dell'informazione genetica.Differenze tra organismi con strategie di riproduzione r e K 107
Complement receptor 1 gene polymorphisms in sarcoidosis. 106
Are Hsp70 protein expression and genetic polymorphism implicated in multiple sclerosis inflammation? 106
The -374T/A variant of the rage gene promoter is associated with clinical restenosis after coronary stent placement 105
Specific polymorphisms of cytokine genes are associated with different risks to develop single-system or multi-system childhood Langerhans cell histiocytosis 102
Genetic study in Northern Italy and comparison with Western European populations 102
Positive association of TNF-857 and IFN G 874 gene polymorphisms with chronic fatigue syndrome 102
Complement receptor 1 polymorphism and haplotypes in coronary artery disease 102
Excess of activating killer cell immunoglobulin-like receptors and lack of HLA-Bw4 ligands: a two-edged weapon in chronic fatigue syndrome 101
Positive association of TNF -857 and IFN-gamma 874 gene polymorphisms with Chronic Fatigue Sindrome. 101
What's new about oral treatments in Multiple Sclerosis? Immunogenetics still under question 101
HLA haplotypes and birth weight variation: is your future going to be light or heavy? 100
Studio di polimorfismi dei geni RAGE, TNF e recettori (TNFR1 e TNFR2) in pazienti con Sclerosi Laterale Amiotrofica (SLA). 99
Polimorfismi del TLR4 e dei geni C4A e C4B nella CFS ( Chronic Fatigue Sindrome) 99
HLA-G gene expression in human blood cells cultured in vitro 99
Regione HLA di classe III 98
Multicentric evaluation of the KIR genotypes in the Italian caucasian population. 98
HLA-I antigen expression on tumor cells: comparison among imprints, frozen and formalin fixed tissues 98
Implicazione del gene RAGE nell’estensione della lesione a livello coronarico in pazienti affetti da CAD 98
L'equilibrio tra conservazione e innovazione a livello dell'informazione genetica: differenze tra organismi con strategie di riproduzione r e K 98
KIR immunogenetics in CFS italian patients 98
Downregulation of genes associated with anti-tumour immune response induced by melatonin 97
The -374T/A RAGE polymorphism protects against future cardiac events in nondiabetic patients with coronary artery disease. 97
Mutations in the 5'UTR region of the Hsp 70-1 gene appear to condition the response to extracorporeal photochemotherapy 97
The Bov-A2 Retroelement Played a Crucial Role in the Evolution of Ruminants 97
Gender difference and autoimmune disease: a study of polymorphic MHC genomic markers in myasthenia gravis (MG) 97
Totale 12.598
Salva come PNG Salva come JPEG
Categoria #
all - tutte 70.091
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 70.091
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022754 0 9 21 15 6 21 18 49 37 18 111 449
2022/20232.796 313 208 34 194 323 301 0 168 1.140 24 65 26
2023/20241.046 140 154 42 54 83 257 39 68 8 34 99 68
2024/20252.361 58 199 101 87 38 105 67 186 621 46 264 589
2025/20265.426 443 359 604 517 666 304 1.179 186 485 384 161 138
2026/2027267 74 193 0 0 0 0 0 0 0 0 0 0
Totale 18.473